Papers by Steven E. Nissen
Page 3 · newest first
- Longitudinal high-sensitivity C-reactive protein and long-term cardiovascular outcomes in optimally-treated patients with high-risk vascular diseaseEuropean Heart Journal · 2021
- Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity: Comparison of Gastric Bypass, Sleeve Gastrectomy, and Usual CareDiabetes Care · 2021
- Chronic Oral Administration of Mineral Oil Compared With Corn Oil: Effects on Gut Permeability and Plasma Inflammatory and Lipid BiomarkersFrontiers in Pharmacology · 2021
- Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for DiabetesAnnals of Surgery · 2021
- Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular RiskJAMA Cardiology · 2021
- Unmet Needs in the Treatment of Hypertrophic CardiomyopathyFuture Cardiology · 2021
- Impact of an electronic medical record-based appointment order on outpatient cardiology follow-up after hospital dischargenpj Digital Medicine · 2021
- Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeuticsCardiovascular Research · 2021
- Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS studyCardiovascular Diagnosis and Therapy · 2021
- Association of Serum Lipoprotein (a) Levels and Coronary Atheroma Volume by Intravascular UltrasoundJournal of the American Heart Association · 2020
- Progression of coronary atherosclerosis in patients without standard modifiable risk factorsAmerican Journal of Preventive Cardiology · 2020
- Cryoballoon Ablation as Initial Therapy for Atrial FibrillationNew England Journal of Medicine · 2020
- Coronary atherosclerotic plaque progression: contributing factors in statin-treated patientsExpert Review of Cardiovascular Therapy · 2020
- How Much Weight Loss is Required for Cardiovascular Benefits? Insights From a Metabolic Surgery Matched-cohort StudyAnnals of Surgery · 2020
- C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOVAmerican Journal of Preventive Cardiology · 2020
- Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)Clinical Cardiology · 2020
- Strengthening the interpretability of clinical trial results by assessing the effect of informative censoring on the primary estimand in PRECISIONClinical Trials · 2020
- Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular DiseaseJAMA Cardiology · 2020
- Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trialBMC Medicine · 2020
- Success (but Unfinished) Story of Metabolic SurgeryDiabetes Care · 2020
- Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER TrialDiabetes Care · 2020
- Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunitiesCardiovascular Endocrinology & Metabolism · 2020
- Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 DiabetesBiomolecules · 2020
- Progression of ultrasound plaque attenuation and low echogenicity associates with major adverse cardiovascular eventsEuropean Heart Journal · 2020
- Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trialBMJ Open Diabetes Research & Care · 2020
- Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning ApproachDiabetes Care · 2020
- Can We Trust the Independence of Cardiovascular Guidelines?Circulation Cardiovascular Quality and Outcomes · 2019
- Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High‐Risk Vascular Disease: Insights From the ACCELERATE TrialJournal of the American Heart Association · 2019
- Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery diseaseEuropean Journal of Preventive Cardiology · 2019
- Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and ObesityJAMA · 2019
- Purpura fulminans manifesting with Staphylococcus aureus endocarditis: a case reportEuropean Heart Journal - Case Reports · 2019
- Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromesEuropean Heart Journal · 2019
- New Model of Automated Patient-Reported Outcomes Applied in Atrial FibrillationCirculation Arrhythmia and Electrophysiology · 2019
- Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trialDiabetes and Vascular Disease Research · 2019
- Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled TrialArthritis & Rheumatology · 2019
- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetesDiabetes and Vascular Disease Research · 2019
- Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysisEuropean Journal of Preventive Cardiology · 2018
- Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety TrialDiabetes Care · 2018
- Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill TestingJAMA Network Open · 2018
- Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women’s Ischemia Syndrome EvaluationCardiovascular Diagnosis and Therapy · 2018
- Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome TrialJAMA Cardiology · 2018
- Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trialAlimentary Pharmacology & Therapeutics · 2018
- The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION TrialLara D. Veeken · 2018
- Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or IbuprofenJournal of the American College of Cardiology · 2018
- Visit-to-visit cholesterol variability correlates with coronary atheroma progression and clinical outcomesEuropean Heart Journal · 2018
- ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular DiseaseJAMA Cardiology · 2018
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2018
- Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid ArthritisArthritis & Rheumatology · 2017
- Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) TrialEuropean Heart Journal · 2017
- Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long‐Term Mortality After Noncardiac Vascular SurgeryJournal of the American Heart Association · 2017